Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of INBX will decline by -3.76% over the next 2 Weeks and hit $85.75 by Tuesday, June 23, 2026. In that time frame, INBX's share price is expected to range between $67.90 and $104.20.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 23, 2026 | 67.90 | 85.75 | 104.20 |
| Jun 22, 2026 | 69.18 | 86.89 | 105.06 |
| Jun 19, 2026 | 61.68 | 80.56 | 99.42 |
| Jun 18, 2026 | 67.28 | 85.57 | 103.36 |
| Jun 17, 2026 | 72.88 | 91.83 | 111.07 |
| Jun 16, 2026 | 69.87 | 87.13 | 106.36 |
| Jun 15, 2026 | 68.66 | 88.27 | 107.95 |
| Jun 12, 2026 | 63.28 | 81.95 | 100.92 |
| Jun 11, 2026 | 68.26 | 86.95 | 105.62 |
| Jun 10, 2026 | 72.90 | 93.21 | 112.46 |
INBX shares fell -0.03% in Tuesday, June 9, 2026's trading session, dropping from a previous close of $89.13 to move at $89.10. The stock demonstrated notable intraday movement (see INBX's key stats for a full breakdown), fluctuating between $85.66 and $93.34, a +8.97% trading range. While recent weeks have seen some volatility, INBX has managed to secure a -16.61% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 248.14K shares changing hands, 53.69K more than the previous session. This amounted to $22.11M in total market activity.
Will INBX Continue Its Upward Trend?
According to analyst ratings and projections for INBX, Inhibrx Biosciences, Inc. shares are anticipated to increase by +14.50%, potentially reaching $104.20 per share by June 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for INBX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the INBX stock forecast, now is a good time to buy INBX stock because its current trading price is +3.91% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on INBX covering social and institutional perspectives.
INBX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into INBX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 32.22% to 42.87%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 49.64%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.31%, maintains a neutral outlook for the long term. Insights into INBX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Inhibrx Biosciences Short-Term Forecasts
INBX Forecast For Next 5 Days
Our algorithm anticipates Inhibrx Biosciences (INBX) stock could hit $89.88 by Jun 16, 2026. This represents a +0.87% fall from today's price, following a -4.00% change over the past five days.
INBX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Inhibrx Biosciences, Inc. (INBX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $90.40, which would mean a +1.46% increase from the current price of $89.10. Projections for this period range from a high of $128.79 to a low of $39.40.
INBX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Inhibrx Biosciences's price over the next three months point to a rise. INBX stock is expected to peak at $104.11 on Aug 31, 2026 after potentially dipping to $76.76 on Jun 16, 2026. On average, INBX is likely to trade around $89.44 in the coming 90 days.
Inhibrx Biosciences Stock Forecast 2025
Based on our predictive models, Inhibrx Biosciences (INBX) is expected to trade between $76.76 and $113.32 throughout 2026. This would result in an average price of $93.73, potentially offering investors a +5.20% return from current levels.
Inhibrx Biosciences, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Inhibrx Biosciences, Inc. (INBX) is positioned to show a strong performance in June 2026. The price is predicted to move between $76.76 and $96.63, settling at an average of $86.81. This could translate to a -2.57% loss.
July 2026
Based on current market signals, Inhibrx Biosciences, Inc. is projected to trend july 2026. We forecast a trading range from $78.53 to $99.32, with a likely average price of $88.84. Investors could expect a potential return of -0.29%.
August 2026
Our predictive algorithms indicate Inhibrx Biosciences, Inc. stock may see a shift in August 2026. The expected range spans $78.61–$104.11, with an average target of $90.46. This represents a positive outlook and a possible gain of +1.53%.
September 2026
Analyzing established trends, Inhibrx Biosciences, Inc. looks set to move in September 2026. Projections place the stock between $84.98 and $112.24, averaging around $97.32. This suggests a +9.23% gain from current levels.
October 2026
Market indicators suggest Inhibrx Biosciences, Inc. could experience notable changes during October 2026. Prices could fluctuate within $84.94 to $113.32, with a midpoint forecast of $100.59. The stock might deliver a +12.90% gain.
November 2026
Forecasting for November 2026, models estimate that Inhibrx Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $84.21 and $107.00, averaging $94.50. This signals a positive trajectory with potential returns around +6.06%.
December 2026
According to our latest forecast models, Inhibrx Biosciences, Inc. (INBX) is positioned to show a strong performance in December 2026. The price is predicted to move between $84.41 and $106.76, settling at an average of $95.44. This could translate to a +7.12% gain.
January 2027
Based on current market signals, Inhibrx Biosciences, Inc. is projected to trend january 2027. We forecast a trading range from $85.47 to $110.19, with a likely average price of $97.79. Investors could expect a potential return of +9.75%.
February 2027
Our predictive algorithms indicate Inhibrx Biosciences, Inc. stock may see a shift in February 2027. The expected range spans $90.39–$118.09, with an average target of $104.19. This represents a positive outlook and a possible gain of +16.94%.
March 2027
Analyzing established trends, Inhibrx Biosciences, Inc. looks set to move in March 2027. Projections place the stock between $95.42 and $120.28, averaging around $107.55. This suggests a +20.71% gain from current levels.
April 2027
Market indicators suggest Inhibrx Biosciences, Inc. could experience notable changes during April 2027. Prices could fluctuate within $88.74 to $112.71, with a midpoint forecast of $100.85. The stock might deliver a +13.19% gain.
May 2027
Forecasting for May 2027, models estimate that Inhibrx Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $92.09 and $112.36, averaging $102.15. This signals a positive trajectory with potential returns around +14.65%.
June 2027
According to our latest forecast models, Inhibrx Biosciences, Inc. (INBX) is positioned to show a strong performance in June 2027. The price is predicted to move between $91.79 and $111.17, settling at an average of $101.80. This could translate to a +14.25% gain.
INBX's history of dividends and stock splits also plays a role in long-term investor confidence.

